Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | Cell Communication and Signaling

Fig. 4

From: GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer

Fig. 4

Construction and validation of the NECGS model. A&D. KM plots and risk curves showing the correlation between NECGS and ARSI response, including ACTL6A, PARP2, and RUVBL1 expression in training and validation sets. B&E. Univariate and multivariate Cox regression analyses of NECGS’s impact on ARSI response in training and validation sets. C&F. ROC curve analyses of NECGS’s predictive efficacy for ARSI response in training and validation sets

Back to article page